Evogene Stock Technical Analysis

EVGN Stock  USD 1.09  0.01  0.93%   
As of the 10th of February, Evogene shows the Mean Deviation of 2.52, variance of 12.86, and Standard Deviation of 3.59. Evogene technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices.

Evogene Momentum Analysis

Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Evogene, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to EvogeneEvogene's Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.

Evogene Analyst Consensus

Target PriceConsensus# of Analysts
2.5Strong Buy2Odds
Evogene current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Evogene analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Evogene stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Evogene, talking to its executives and customers, or listening to Evogene conference calls.
Evogene Analyst Advice Details
Will Biotechnology sector continue expanding? Could Evogene diversify its offerings? Factors like these will boost the valuation of Evogene. Projected growth potential of Evogene fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Evogene data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share
(1.10)
Revenue Per Share
1.084
Quarterly Revenue Growth
(0.83)
Return On Assets
(0.31)
Return On Equity
(0.71)
Investors evaluate Evogene using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Evogene's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Evogene's market price to deviate significantly from intrinsic value.
It's important to distinguish between Evogene's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Evogene should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Evogene's market price signifies the transaction level at which participants voluntarily complete trades.

Evogene 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Evogene's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Evogene.
0.00
11/12/2025
No Change 0.00  0.0 
In 2 months and 31 days
02/10/2026
0.00
If you would invest  0.00  in Evogene on November 12, 2025 and sell it all today you would earn a total of 0.00 from holding Evogene or generate 0.0% return on investment in Evogene over 90 days. Evogene is related to or competes with GeoVax Labs, BioLineRx, Tharimmune, Ainos, and Lipocine. Evogene Ltd., together with its subsidiaries, operates as a computational biology company More

Evogene Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Evogene's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Evogene upside and downside potential and time the market with a certain degree of confidence.

Evogene Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Evogene's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Evogene's standard deviation. In reality, there are many statistical measures that can use Evogene historical prices to predict the future Evogene's volatility.
Hype
Prediction
LowEstimatedHigh
0.051.084.74
Details
Intrinsic
Valuation
LowRealHigh
0.071.435.09
Details
2 Analysts
Consensus
LowTargetHigh
2.282.502.78
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.34-0.34-0.34
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Evogene. Your research has to be compared to or analyzed against Evogene's peers to derive any actionable benefits. When done correctly, Evogene's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Evogene.

Evogene February 10, 2026 Technical Indicators

Evogene Backtested Returns

Evogene secures Sharpe Ratio (or Efficiency) of -0.0448, which denotes the company had a -0.0448 % return per unit of risk over the last 3 months. Evogene exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Evogene's Standard Deviation of 3.59, mean deviation of 2.52, and Variance of 12.86 to check the risk estimate we provide. The firm shows a Beta (market volatility) of 0.77, which means possible diversification benefits within a given portfolio. As returns on the market increase, Evogene's returns are expected to increase less than the market. However, during the bear market, the loss of holding Evogene is expected to be smaller as well. At this point, Evogene has a negative expected return of -0.16%. Please make sure to confirm Evogene's information ratio, potential upside, as well as the relationship between the Potential Upside and rate of daily change , to decide if Evogene performance from the past will be repeated at some point in the near future.

Auto-correlation

    
  0.00  

No correlation between past and present

Evogene has no correlation between past and present. Overlapping area represents the amount of predictability between Evogene time series from 12th of November 2025 to 27th of December 2025 and 27th of December 2025 to 10th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Evogene price movement. The serial correlation of 0.0 indicates that just 0.0% of current Evogene price fluctuation can be explain by its past prices.
Correlation Coefficient0.0
Spearman Rank Test0.23
Residual Average0.0
Price Variance0.0
Evogene technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Evogene technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Evogene trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Evogene Technical Analysis

Indicator
Time Period
Execute Indicator
The output start index for this execution was one with a total number of output elements of sixty. The Normalized Average True Range is used to analyze tradable apportunities for Evogene across different markets.

About Evogene Technical Analysis

The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Evogene on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Evogene based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Evogene price pattern first instead of the macroeconomic environment surrounding Evogene. By analyzing Evogene's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Evogene's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Evogene specific price patterns or momentum indicators. Please read more on our technical analysis page.
 2023 2024 2025 2026 (projected)
Interest Debt Per Share0.252.232.012.11
Revenue Per Share0.121.471.691.77

Evogene February 10, 2026 Technical Indicators

Most technical analysis of Evogene help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Evogene from various momentum indicators to cycle indicators. When you analyze Evogene charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

Evogene February 10, 2026 Daily Trend Indicators

Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Evogene stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
When determining whether Evogene offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Evogene's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Evogene Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Evogene Stock:
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Evogene. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census.
To learn how to invest in Evogene Stock, please use our How to Invest in Evogene guide.
You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Will Biotechnology sector continue expanding? Could Evogene diversify its offerings? Factors like these will boost the valuation of Evogene. Projected growth potential of Evogene fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Evogene data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share
(1.10)
Revenue Per Share
1.084
Quarterly Revenue Growth
(0.83)
Return On Assets
(0.31)
Return On Equity
(0.71)
Investors evaluate Evogene using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Evogene's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Evogene's market price to deviate significantly from intrinsic value.
It's important to distinguish between Evogene's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Evogene should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Evogene's market price signifies the transaction level at which participants voluntarily complete trades.